List of Oncopeptides patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10543274 Lyophilized preparation of cytotoxic dipeptides	Patent 10543274 was granted and assigned to Oncopeptides on January, 2020 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10543274	January 28, 2020
‌ US Patent 11344622 Lyophilized preparation of cytotoxic dipeptides		Oncopeptides	Oncopeptides	United States Patent and Trademark Office	11344622	May 31, 2022
‌ US Patent 10322182 Lyophilized preparation of cytotoxic dipeptides	Patent 10322182 was granted and assigned to Oncopeptides on June, 2019 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10322182	June 18, 2019
‌ US Patent 10869928 Lyophilized preparation of cytotoxic dipeptides	Patent 10869928 was granted and assigned to Oncopeptides on December, 2020 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10869928	December 22, 2020
‌ US Patent 10285946 Lyophilized preparations of melphalan flufenamide	Patent 10285946 was granted and assigned to Oncopeptides on May, 2019 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10285946	May 14, 2019
‌ US Patent 10285947 Lyophilized preparations of melphalan flufenamide	Patent 10285947 was granted and assigned to Oncopeptides on May, 2019 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10285947	May 14, 2019
‌ US Patent 10287316 Process for preparation of nitrogen mustard derivatives	Patent 10287316 was granted and assigned to Oncopeptides on May, 2019 by the United States Patent and Trademark Office.	Oncopeptides	Oncopeptides	United States Patent and Trademark Office	10287316	May 14, 2019
‌ US Patent 6992207 Melphalan derivatives and their use as cancer chemotherapeutic drugs	Patent 6992207 was granted and assigned to Oncopeptides on January, 2006 by the United States Patent and Trademark Office.		Oncopeptides	United States Patent and Trademark Office	6992207	January 31, 2006